Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early stage breast cancer: A prospective trial

被引：1
|
作者：
Haddad, Tufia C.
Suman, Vera
Giridhar, Karthik V.
Moreno-Aspitia, Alvaro
Northfelt, Donald
Ernst, Brenda
Sideras, Kostandinos
O'Sullivan, Ciara C.
Singh, Ravinder
Desta, Zeruesenay
Taraba, Jodi
Goodnature, Barbara
Goetz, Matthew P.
Wang, Liewei
Ingle, James N.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-OT1-04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-04-02
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Memory impairments with anastrozole versus tamoxifen therapy in women with early stage breast cancer
    Bender, CM
    Sereika, SM
    Ryan, CM
    Casillo, FE
    Vogel, VG
    Berga, SL
    Cohen, SM
    Rastogi, P
    Brufsky, AM
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S274 - S274
  • [42] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    Rutqvist, LE
    Hatschek, T
    Ryden, S
    Bergh, J
    Bengtsson, NO
    Carstenssen, J
    Nordenskjold, B
    Wallgren, A
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) : 1543 - 1549
  • [43] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
    Machin, D
    Andersen, KW
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09): : 659 - 659
  • [44] Adherence with adjuvant anastrozole therapy among women with early stage breast cancer.
    Partridge, A. H.
    LaFountain, A.
    Taylor, B.
    Asnis-Alibozek, A.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S186 - S186
  • [45] Review of the ATAC study: tamoxifen versus anastrozole in early-stage breast cancer
    Needleman, Sarah J.
    Tobias, Jeffrey S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (12) : 1871 - 1881
  • [46] Prognostic performance of Breast Cancer Index (BCI) in postmenopausal women with early-stage HR plus breast cancer in the TEAM trial
    Bartlett, J. M.
    Xu, K.
    Wong, J.
    Pond, G.
    Zhang, Y.
    Spears, M.
    Salunga, R.
    Mallon, E.
    Taylor, K. J.
    Hasenburg, A.
    Markopoulos, C.
    Dirix, L. Y.
    Seynaeve, C.
    van de Velde, C.
    Rea, D.
    Schnabel, C. A.
    Treuner, K.
    Bayani, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S602 - S602
  • [47] Dose dense chemotherapy for early stage breast cancer
    Huds, C.
    EJC SUPPLEMENTS, 2004, 2 (03): : 119 - 119
  • [48] A cost-effectiveness analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with early-stage breast cancer in Mexico
    Mould-Quevedo, J.
    Tapia-Valencia, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2007, 10 (03) : A124 - A125
  • [49] Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole
    Menada, Mario Valenzano
    Costantini, Sergio
    Moioli, Melita
    Bogliolo, Stefano
    Papadia, Andrea
    Ferrero, Simone
    Dugnani, Maria Cristina
    BREAST, 2008, 17 (06): : 631 - 636
  • [50] Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
    Williams, Norman
    LANCET ONCOLOGY, 2008, 9 (01): : 45 - 53
12345